4//SEC Filing
Levy Adam Scott 4
Accession 0001693134-26-000002
CIK 0001933414other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 8:43 PM ET
Size
5.3 KB
Accession
0001693134-26-000002
Insider Transaction Report
Form 4
Levy Adam Scott
CFO and Secretary
Transactions
- Sale
Common Stock
[F1][F2]2026-01-12$32.14/sh−10,758$345,723→ 8,638 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $31.90 to $32.37. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
Signature
/s/ Adam Levy|2026-01-13
Documents
Issuer
Mineralys Therapeutics, Inc.
CIK 0001933414
Entity typeother
Related Parties
1- filerCIK 0001693134
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 8:43 PM ET
- Size
- 5.3 KB